Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV Vaccination Delivery in Tanzanian Girls
NCT01173900Phase 4Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Aug 2010
- Primary completion
- Aug 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of qHPV vaccine in Cervical Cancer (CC) (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoints: Vaccine coverage by delivery strategy at Month 12, Vaccine coverage (dose 2) by delivery strategy at Month 5 and 1 more. Started Aug 2010; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01173900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173900.